Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (61-70 of 10,652) with videos related to

Pageof 1,066
Sort By:
Current Pharmaceutical Design|January 20, 2009
Imatinib and its successors--how modern chemistry has changed drug developmentBernhard A Müller
Current Pharmaceutical Design|January 20, 2009
Targeting redox signaling in the vascular wall: from basic science to clinical practiceCharalambos Antoniades, Alexios S Antonopoulos, Jennifer K Bendall, et al.
Current Pharmaceutical Design|August 12, 2010
Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disordersMakoto Naoi, Wakako Maruyama
Current Pharmaceutical Design|August 12, 2010
Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's diseaseMiguel Medina, Jesús Avila
Current Pharmaceutical Design|March 12, 2011
Pharmacological activation of p53 in cancer cellsMohammad Athar, Craig A Elmets, Levy Kopelovich
Current Pharmaceutical Design|March 12, 2011
Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 updateMelissa Millard, Divya Pathania, Fedora Grande, et al.
Current Pharmaceutical Design|April 16, 2011
Food addiction and neuroimagingYi Zhang, Karen M von Deneen, Jie Tian, et al.
Current Pharmaceutical Design|April 16, 2011
Should overeating and obesity be classified as an addictive disorder in DSM-5?Claudia Moreno, Rajiv Tandon
Current Pharmaceutical Design|March 23, 2011
Cardiovascular disease: focus on dyslipidemiaI Gouni-Berthold
Current Pharmaceutical Design|March 23, 2011
Lipid management for the prevention of cardiovascular diseaseJuergen R Schaefer
Pageof 1,066

Showing results (61-70 of 10,652) with videos related to

Sort By:
Pageof 1,066
Current Pharmaceutical Design|January 20, 2009
Imatinib and its successors--how modern chemistry has changed drug developmentBernhard A Müller
Current Pharmaceutical Design|January 20, 2009
Targeting redox signaling in the vascular wall: from basic science to clinical practiceCharalambos Antoniades, Alexios S Antonopoulos, Jennifer K Bendall, et al.
Current Pharmaceutical Design|August 12, 2010
Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disordersMakoto Naoi, Wakako Maruyama
Current Pharmaceutical Design|August 12, 2010
Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's diseaseMiguel Medina, Jesús Avila
Current Pharmaceutical Design|March 12, 2011
Pharmacological activation of p53 in cancer cellsMohammad Athar, Craig A Elmets, Levy Kopelovich
Current Pharmaceutical Design|March 12, 2011
Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 updateMelissa Millard, Divya Pathania, Fedora Grande, et al.
Current Pharmaceutical Design|April 16, 2011
Food addiction and neuroimagingYi Zhang, Karen M von Deneen, Jie Tian, et al.
Current Pharmaceutical Design|April 16, 2011
Should overeating and obesity be classified as an addictive disorder in DSM-5?Claudia Moreno, Rajiv Tandon
Current Pharmaceutical Design|March 23, 2011
Cardiovascular disease: focus on dyslipidemiaI Gouni-Berthold
Current Pharmaceutical Design|March 23, 2011
Lipid management for the prevention of cardiovascular diseaseJuergen R Schaefer
Pageof 1,066